Abiopharma

🔍 Ramaswamy Vivek (Executive)

Company: Roivant Sciences Ltd. (ROIV)

Report Date: 2025-09-03

Detailed Transactions and Holdings:

• Sold 1,195,000 shares of Common Shares at $12.5 per share (Direct)
  Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 36,089,108.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 194,933 shares of Common Shares at $12.92 per share (Direct)
  Date: 2025-09-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,894,175.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 385,816 shares of Common Shares at $12.96 per share (Direct)
  Date: 2025-09-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,508,359.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Shares (Direct)
  Date: 2025-09-03 | Code: H | nature_of_ownership: Spousal | shares_owned_after: 13,357,857.00 | Footnotes: F4

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $12.71, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.04, inclusive.
• F4: Represents the quantity of shares held indirectly only.